Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahsa Abassi

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in UgandaAnna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical TrialDavid R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
The Journal of Infectious Diseases|June 18, 2026
Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitisMartineau Louine, Ravi Dandekar, Sumanth P Reddy, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in UgandaAnna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical TrialDavid R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
The Journal of Infectious Diseases|June 18, 2026
Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitisMartineau Louine, Ravi Dandekar, Sumanth P Reddy, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Pageof 6